Litigation Details for Bausch Health US, LLC v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2018)
✉ Email this page to a colleague
Bausch Health US, LLC v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2018)
| Docket | ⤷ Sign Up | Date Filed | 2018-09-27 |
| Court | District Court, N.D. West Virginia | Date Terminated | 2021-01-05 |
| Cause | 35:271 Patent Infringement | Assigned To | Irene Patricia Murphy Keeley |
| Jury Demand | None | Referred To | |
| Parties | DOW PHARMACEUTICAL SCIENCES, INC. | ||
| Patents | 7,214,506; 8,039,494; 8,486,978; 9,302,009; 9,566,272; 9,662,394; 9,861,698; 9,877,955 | ||
| Attorneys | James F. Companion | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Bausch Health US, LLC v. Mylan Pharmaceuticals Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Bausch Health US, LLC v. Mylan Pharmaceuticals Inc. (N.D.W. Va. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2018-09-27 | 1 | Complaint (NOT for attorney use) | United States Patent Nos. 7,214,506 (“the ‘506 patent”), 8,039,494 (“the ‘494 patent”), 8,486,978 (“…506 patent, the ‘494 patent, the ‘978 patent, the ‘009 patent, the ‘272 patent, the ‘394 patent, the …‘506 patent, the ‘494 patent, the ‘978 patent, the ‘009 patent, the ‘272 patent, the ‘394 patent, the…‘506 patent, the ‘494 patent, the ‘978 patent, the ‘009 patent, the ‘272 patent, the ‘394 patent, the…506 patent, the ‘494 patent, the ‘978 patent, the ‘009 patent, the ‘272 patent, the ‘394 patent, the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
